Related case:
CAS 2011_A_2518 Robert Kendrick vs ITF
November 10, 2011
In June 2011 the International Tennis Federation (ITF) has reported an anti doping rule violation against the American tennis player Robert Kendrick after his sample tested positive for the prohibited substance 4-Methylhexan-2-amine (methylhexaneamine, 1,3-dimethylamylamine, 1,3 DMAA).
Following notification the Athlete gave a prompt admission and accepted a provisional suspension. He filed a statement in his defence and was heard for the ITF Independent Anti-Doping Tribunal.
The Athlete explained that he had used Zija XM3 capsules, provided by a teaching tennis professional, to reduce the effect of jetlag. He had established that the product did not contain a prohibited substance following internet research about the product ingredients.
The Tribunal accepts that the violation was not intentional, yet it finds that he had acted negligently. The Tribunal deems that the Athlete failed to consult a medical practitioner because of his jetlag concerns, nor did he contact the USADA or the ITF hotline in order to obtain advice about the product.
Therefore the International Tennis Federation Independent Anti-Doping Tribunal’s decides on 29 July 2011:
(1) Confirms the commission of the doping offence specified in the Charge;
(2) Orders that Mr Kendrick’s individual result must be disqualified in respect of the French Open 2011, and in consequence rules that the 10 ranking points and € 15.000 in prize money obtained by him from his participation in that event must be forfeited;
(3) Orders further that Mr Kendrick be permitted to retain the prize money obtained by him from his participation in the subsequent UNICEF Open;
(4) Finds that Mr Kendrick has established that the circumstances of his doping offence bring him within the provisions of Article M.4 of the Programme;
(5) Declares Mr Kendrick ineligible for a period of 12 months, commencing on 22 May 2011, from participating in any capacity in any event or activity (other than authorised anti-doping education or rehabilitation programmes) authorised by the ITF or by any national or regional entity which is a member of the ITF or is recognised by the ITF as the entity governing the sport of tennis in that nation or region.
